~38 spots leftby Apr 2026

ADHD Interventions + Stimulant for ADHD

Recruiting in Palo Alto (17 mi)
+1 other location
Age: Any Age
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Recruiting
Sponsor: Florida International University
Must not be taking: Stimulants
Disqualifiers: Special education, IQ < 70, Psychosis, others
No Placebo Group
Prior Safety Data

Trial Summary

What is the purpose of this trial?

This trial tests different ways to help children with ADHD behave better in school. It starts with general classroom techniques, adds more focused help if needed, and uses advanced methods or medication if necessary. The study targets young children with ADHD who are not in special education or on medication. Medication has been extensively studied and shown to improve ADHD symptoms in children.

Will I have to stop taking my current medications?

The trial does not specify if participants must stop taking their current medications. However, children with a history of successful treatment with stimulant medication are excluded from the study.

What data supports the effectiveness of this treatment for ADHD?

Research shows that teacher-delivered behavioral classroom interventions can be effective for students with ADHD, and stimulant medications like Ritalin and Adderall have been shown to improve symptoms in over 90% of students initially, with 76% maintaining improvement over a school year.12345

Is the combination of ADHD interventions and stimulants safe for humans?

Stimulants used for ADHD, like Ritalin and Adderall, are generally safe but have a potential for misuse and abuse. It's important to monitor their use, especially in school settings, to prevent misuse and ensure they are stored securely.12467

How is the Tier 1 Classroom Management treatment for ADHD different from other treatments?

Tier 1 Classroom Management is unique because it involves teachers using specific strategies to manage behavior in the classroom, rather than relying solely on medication. This approach focuses on creating a structured environment and using behavior therapy techniques to help students with ADHD, which can also positively impact their classmates.148910

Research Team

Eligibility Criteria

This trial is for children in grades 1-5 diagnosed with ADHD according to DSM-V criteria. It's not suitable for kids who've had successful ADHD treatment with stimulants, those in special education due to behavior issues, have an IQ under 70, psychosis or pervasive developmental disorders, are already part of the study, or are home-schooled.

Inclusion Criteria

Child meets DSM-V diagnostic criteria for Attention-Deficit/Hyperactivity Disorder

Exclusion Criteria

Child has psychosis or a pervasive developmental disorder
Child is in a classroom that already has a study participant
Child is home-schooled
See 3 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Tier 1 Intervention

Participants receive Tier 1 classroom-wide management strategies as part of the RTI approach

Throughout the academic year
Regular school visits

Tier 2 Intervention

Participants who do not respond to Tier 1 receive a Daily Report Card (DRC) intervention

Throughout the academic year
Regular school visits

Enhanced RTI or Medication

Participants who do not respond to Tier 2 are randomly assigned to either enhanced RTI strategies or receive stimulant medication

Throughout the academic year
Regular school visits

Follow-up

Participants are monitored for safety and effectiveness after interventions

End of academic year

Treatment Details

Interventions

  • Daily Report Card (DRC) (Behavioural Intervention)
  • Enhanced DRC (DRC-E) (Behavioural Intervention)
  • Stimulant (Hormone Therapy)
  • Tier 1 Classroom Management (Behavioural Intervention)
Trial OverviewThe study tests Tier 1 classroom management and Tier 2 interventions within a Response to Intervention (RTI) framework against typical support strategies. If initial responses fail, it will compare enhanced Tier 2 strategies versus stimulant medication using a SMART design.
Participant Groups
5Treatment groups
Experimental Treatment
Active Control
Group I: Response to Intervention (RTI): Tier 1Experimental Treatment1 Intervention
Two-thirds of participants will be assigned to the RTI Tier 1 Arm. Teachers of students in this arm will receive consultation in RTI Tier 1 Classroom Management strategies.
Group II: RTI: EnhancedExperimental Treatment3 Interventions
Half of students in the RTI DRC Arm who do not respond to the DRC intervention will be randomly assigned to the RTI: Enhanced Arm. Students in this arm will receive a more intensive classroom behavioral intervention directed at individual target behaviors through an enhanced DRC.
Group III: RTI: Daily Report Card (DRC)Experimental Treatment2 Interventions
Students assigned to the RTI Tier 1 Arm, who do not respond to the initial RTI Tier 1 Classroom Management strategies, will move to the RTI DRC Arm of the study. Teachers of students in this arm of the study will receive consultation to implement a daily report card.
Group IV: MedicationExperimental Treatment3 Interventions
Half of students in the RTI DRC Arm who do not respond to the DRC intervention will be randomly assigned to the Medication arm and will receive stimulant medication as an additional intervention.
Group V: Business as Usual (BAU)Active Control1 Intervention
One-third of participants will be assigned to this condition and will receive academic accommodations and interventions as deemed appropriate by their teachers, school personnel, and parents. This condition is intended to mirror current standard procedures for youth with ADHD. Thus, the specific accommodations and interventions are expected to vary across students. Some students' parents and physicians may choose to start stimulant medication with a goal of improving classroom performance.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Florida International University

Lead Sponsor

Trials
114
Recruited
19,400+

Andrés G. Gil

Florida International University

Chief Executive Officer

PhD in Medical Sociology from the University of Miami

Dr. Stuart Hart

Florida International University

Chief Medical Officer

MD from Harvard Medical School

University at Buffalo

Collaborator

Trials
139
Recruited
105,000+
Satish K. Tripathi profile image

Satish K. Tripathi

University at Buffalo

Chief Executive Officer since 2011

PhD in Computer Science from University of Toronto

Brian M. Parker profile image

Brian M. Parker

University at Buffalo

Chief Medical Officer since 2021

MD from University of Pennsylvania

Findings from Research

The study will pilot test a resource package called Positive Behavior Management Implementation Resources (PBMIR) to help teachers effectively implement behavioral classroom management strategies for students with ADHD symptoms, using a randomized controlled trial design with two groups.
Outcomes will be measured for both teachers and students over an 8-week period, focusing on the fidelity of intervention implementation and improvements in ADHD-related symptoms and academic performance, which could lead to larger-scale evaluations if successful.
Implementation resources to support teachers' use of behavioral classroom interventions: protocol of a randomized pilot trial.Lawson, GM., Owens, JS., Mandell, DS., et al.[2023]
In a study of 176 students receiving stimulant medication for hyperactivity/inattentiveness, about 75% had pre-treatment ratings indicating moderate to severe symptoms, highlighting the severity of their conditions before treatment.
Over 90% of these students showed at least a 50% improvement in symptoms after starting medication, with 76% maintaining this improvement by the end of the school year, although effectiveness and compliance decreased in middle school.
Hyperactivity and inattentiveness. School assessment of stimulant treatment.Safer, D., Krager, JM.[2017]
Children with ADHD often struggle with behavior, social skills, and academic performance, and while medication can help, it usually isn't enough to fully address their challenges in school.
The article highlights three effective strategies—behavioral, academic, and self-regulation interventions—that can support children with ADHD in the classroom, suggesting a need for more research on these school-based approaches.
School-based interventions for elementary school students with ADHD.DuPaul, GJ., Gormley, MJ., Laracy, SD.[2014]

References

Implementation resources to support teachers' use of behavioral classroom interventions: protocol of a randomized pilot trial. [2023]
Hyperactivity and inattentiveness. School assessment of stimulant treatment. [2017]
School-based interventions for elementary school students with ADHD. [2014]
Stimulant use and the potential for abuse in Wisconsin as reported by school administrators and longitudinally followed children. [2019]
Treatment of attention deficit hyperactivity disorder: a multi-modal model for schools. [2005]
Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I. [2013]
Universal precautions to reduce stimulant misuse in treating adult ADHD. [2015]
Development of a school-wide behavior program in a public middle school: an illustration of deployment-focused intervention development, stage 1. [2015]
[General practice of pedagogic management by teachers of hyperkinetic attention deficit disordered children in the classroom]. [2019]
10.United Statespubmed.ncbi.nlm.nih.gov
The Effects of Classroom Interventions on Off-Task and Disruptive Classroom Behavior in Children with Symptoms of Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review. [2019]